A

NeurovascularMedicine.com
The contents are under continuing development and improvements and may contain errors of omission or fact. The official launch will be at the end of 2018. Feedback vital and always welcome at drokane at gmail.com. This is not to be used for the assessment, diagnosis or management of patients. It should not be regarded as medical advice. It is only for educational purposes. Please adhere to your local protocols. If you are unwell please seek healthcare advice from your doctor. This does not replace senior or specialist advice. If you do not accept this then please do not use the website.

Giant Cell (Temporal) Arteritis


Learning objectives

  • What is Giant Cell (Temporal) Arteritis
  • Appropriate investigations of Giant Cell (Temporal) Arteritis
  • Managing the patient with Giant Cell (Temporal) Arteritis

Introduction

  • This is a rare cause of vasculitis.
  • Sight loss due to an anterior ischaemic optic neuropathy which if bilateral can lead to complete blindness.
  • Early diagnosis and treatment is vital.
  • GCA affects both sexes but is commoner in females.

Aetiology

  • In GCA there us inflammation of small and mid sized arteries usually affecting the external branches of the carotid artery with vascular narrowing.
  • Most commonly the inflammatory vasculitis may affect the superficial temporal arteries and posterior ciliary branch of the ophthalmic artery.
  • It is thought that the immune attack may be to the internal elastic lamina of the vessel wall. Involvement of the internal carotid artery and its branches is uncommon.

Clinical

  • Patients are usually over 60 but some present earlier.
  • They may complain of days or weeks of headache, myalgia.
  • There may be jaw and even tongue claudication precipitated when chewing.
  • Inquire after systemic symptoms including weight loss, malaise, fever.
  • Seen as they may present like a TIA with transient or permanent monocular visual loss.
  • Visual loss may be misdiagnosed as amaurosis or migraine.
  • Fundoscopy in an affected eye with an anterior ischaemic optic neuropathy shows white optic disc oedema with splinter haemorrhages along the disc margin.
  • There may be thickened nodular temporal arteries with tenderness.
  • There are exceptional presentations with stroke which may be anterior or posterior circulation.
  • Strokes however may simply be coincidental and are not uncommon in this age group.

Investigations

  • FBC: there may be a non specific normocytic normochromic anaemia.
  • ESR and CRP: The ESR is usually markedly elevated at over 100 mm/hr and should at least be over 50 for the diagnosis. The CRP should also be elevated.
  • ALP: There is often an elevated ALP is also seen.
  • Temporal artery ultrasound may show distinctive thickening and a halo appearance due to swelling and oedema in the vessel wall. The halo usually disappears with treatment.
  • MRI: some different modalities are being explored as an alternative to biopsy
  • Temporal artery biopsy (TAB):needed within days of starting steroids. The key finding is the presence of giant cells and inflammation of the vessels. The pathology is patchy with skip lesions so a negative biopsy may mean failure to biopsy affected segments of the vessel.

American College of Rheumatology criteria for GCA
1.Age 50 years or older
2.New-onset localised headache
3.Temporal artery tenderness or decreased temporal artery pulse
4.Temporal artery biopsy characterised by mononuclear infiltration or granulomatous inflammation
5.ESR > 50 mm/h
Three of the above five criteria were required to diagnose GCA

*The Sensitivity of the ACR criteria ARE 93.5% and a reported specificity of 91.2% for the classification of giant-cell arteritis compared with other vasculitides.

Management

  • Management is normally High dose steroids started immediately to avoid further potential visual loss on the basis of clinical history and elevated CRP/ESR
  • Stat dose of Prednisolone 1 mg/kg usually is given and usually results in a dramatic reduction of other symptoms too.
  • A temporal artery biopsy is the gold standard and should be done within days but treatment is often continued when biopsy negative if the other criteria are meet. Temporal artery ultrasound may also be useful.
  • Steroids are reduced slowly over 18-24 months titrated to clinical response and ESR/CRP.
  • Steroid sparing agents may be used. Other more potent anti-inflammatory treatment may be given if there is suspected cerebral involvement.
  • Start Osteoporotic Bone protection. Advisable to also consider Aspirin 75 mg od if tolerated as well as good BP and vascular risk factor management.
  • Sadly most patients with GCA experience steroid related complications. These are not insignificant and particularly in patients of advanced age have associated morbidity and even mortality and include diabetes mellitus, osteoporosis with vertebral compression fractures and Cushing syndrome. Steroid sparing agents such as methotrexate have not shown equivalence.

Note: The plan is to keep the website free through donations and advertisers that do not present any conflicts of interest. I am keen to advertise courses and conferences. If you have found the site useful or have any constructive comments please write to me at drokane (at) gmail.com. I keep a list of patrons to whom I am indebted who have contributed. If you would like to advertise a course or conference then please contact me directly for costs and to discuss a sponsored link from this site.

free web counter